← All organizations
Highest phase reached
Phase 2
First clinical trial
May 1, 2009Last known activity
Oct 31, 2021
Timeline
1990s
- Jun 1, 1997
Noxxon AG— Founded
Drugs by trial phase (6 distinct, 15 trials)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
- Albuminuria
- Anemia
- Chronic Disease
- Colorectal Neoplasms
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Endotoxemia
- Glioblastoma
- Inflammation
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Lupus Erythematosus, Systemic
- Multiple Myeloma
- Neoplasms, Plasma Cell
- Pancreatic Neoplasms
- Renal Insufficiency
Recent trials (26)
- NCT04901741Lead sponsorPhase 2Oct 31, 2021
- NCT04121455Lead sponsorPhase 1/Phase 2Sep 12, 2019
- NCT03168139Lead sponsorPhase 1/Phase 2Apr 18, 2017
- NCT02079896Lead sponsorPhase 1/Phase 2May 1, 2014
- NCT02079896Study directorPhase 1/Phase 2May 1, 2014
- NCT01691040Study directorPhase 2Sep 1, 2012
- NCT01691040Lead sponsorPhase 2Sep 1, 2012
- NCT01486797Study directorPhase 2Mar 1, 2012
- NCT01521533Lead sponsorPhase 2Mar 1, 2012
- NCT01547897Lead sponsorPhase 2Mar 1, 2012
- NCT01547897Study directorPhase 2Mar 1, 2012
- NCT01521533Study directorPhase 2Mar 1, 2012
- NCT01486797Lead sponsorPhase 2Mar 1, 2012
- NCT01522794Study directorPhase 1Jan 1, 2012
- NCT01522794Lead sponsorPhase 1Jan 1, 2012
Details
- Founded
- Berlin, DE Jun 1, 1997
- Last known activity
- Oct 31, 2021